CN Patent

CN110870855A — 一种吸入用乙酰半胱氨酸溶液制剂及其制备方法

Assigned to Beijing Kerui Innovative Drug Research Co Ltd · Expires 2020-03-10 · 6y expired

What this patent protects

本发明提供一种乙酰半胱氨酸雾化吸入用溶液制剂及其制备方法。本发明的乙酰半胱氨酸雾化吸入用溶液制剂包括：乙酰半胱氨酸、其盐和/或其水合物；pH调节剂；和溶剂。本发明的乙酰半胱氨酸雾化吸入用溶液制剂具有高效、低毒、稳定性好、安全度高的特点。

USPTO Abstract

本发明提供一种乙酰半胱氨酸雾化吸入用溶液制剂及其制备方法。本发明的乙酰半胱氨酸雾化吸入用溶液制剂包括：乙酰半胱氨酸、其盐和/或其水合物；pH调节剂；和溶剂。本发明的乙酰半胱氨酸雾化吸入用溶液制剂具有高效、低毒、稳定性好、安全度高的特点。

Drugs covered by this patent

Patent Metadata

Patent number
CN110870855A
Jurisdiction
CN
Classification
—
Expires
2020-03-10
Drug substance claim
No
Drug product claim
No
Assignee
Beijing Kerui Innovative Drug Research Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.